Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1

被引:89
作者
Chang, JT
Wang, HM
Chang, KW
Chen, WH
Wen, MC
Hsu, YM
Yung, BYM
Chen, IH
Liao, CT
Hsieh, LL
Cheng, AJ
机构
[1] Chang Gung Univ, Grad Inst Med Biotechnol, Taoyuan 333, Taiwan
[2] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Internal Oncol, Div Hematol Oncol, Taoyuan, Taiwan
[4] Natl Yang Ming Univ, Sch Dent, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Oral Surg, Taoyuan, Taiwan
[6] Chang Gung Univ, Grad Inst Basic Med Sci, Sch Publ Hlth, Taoyuan, Taiwan
[7] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan
关键词
oral cancer; differential expression; clinical association; differentiation;
D O I
10.1002/ijc.20663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To identify cellular genes that could potentially serve as predictive molecular markers for human oral cancer, we employed differential display analysis to compare the gene expression profiles between oral squamous cell carcinoma (OSCC) and histopathologically normal epithelium tissues. Comparative real-time RT-PCR was used to confirm the gene expression in 52 OSCC patients, and a 2-fold difference was defined as over- or underexpression. A total of 7 genes were identified: NPM, CDK1, NDRG1, HMGCR, EF1A, NAC and CRES1. In the cancer tissues, NPM, CDK1 and NDRG1 were significantly overexpressed (an average of 7.6-, 17.2- and 12.9-fold, respectively), and CHES1 was underexpressed (15-fold). The frequencies of the differential expression were 40, 56, 67 and 46%, respectively in NPM, CDK1, NDRG1 and CHES1. In Western blot analysis, the protein expressions of NPM, CDK1 and NDRG1 were also increased in the cancer tissues, consistent with the mRNA expression results. To further evaluate clinicopathological associations in these genes, Pearson chi-square analysis was employed. Levels of CDK1 and NDRG1 were associated with poorly differentiated tumors (p = 0.043 and 0.023), suggesting that these genes participate in the mechanism of tumor transformation. Expressions of CDK1 and NDRG1, and CDK1 and CHES1 were mutually statistically correlated (p = 0.001 and 0.014), indicating that these genes share a very close regulatory relationship or interact synergistically in oncogenesis. In conclusion, we identified 7 genes that are differentially expressed in OSCC, and we provide the first evidence that NPM, CDK1 and NDRG1 are overexpressed and CRES1 is underexpressed in oral cancer. These results serve as a fundamental base for employing these genes in future clinical applications. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:942 / 949
页数:8
相关论文
共 51 条
[1]  
Bandyopadhyay S, 2003, CANCER RES, V63, P1731
[2]   THE PRIMARY STRUCTURE OF THE ALPHA-SUBUNIT OF HUMAN ELONGATION FACTOR-I - STRUCTURAL ASPECTS OF GUANINE-NUCLEOTIDE-BINDING SITES [J].
BRANDS, JHGM ;
MAASSEN, JA ;
VANHEMERT, FJ ;
AMONS, R ;
MOLLER, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 155 (01) :167-171
[3]   Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells [J].
Cangul, H ;
Salnikow, K ;
Yee, H ;
Zagzag, D ;
Commes, T ;
Costa, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 :783-788
[4]   CHARACTERIZATION OF THE CDNA-ENCODING HUMAN NUCLEOPHOSMIN AND STUDIES OF ITS ROLE IN NORMAL AND ABNORMAL GROWTH [J].
CHAN, WY ;
LIU, QR ;
BORJIGIN, J ;
BUSCH, H ;
RENNERT, OM ;
TEASE, LA ;
CHAN, PK .
BIOCHEMISTRY, 1989, 28 (03) :1033-1039
[5]  
Chang JH, 1998, BIOCHEM J, V329, P539
[6]   A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients [J].
Chang, JT ;
Chen, IH ;
Liao, CT ;
Wang, HM ;
Hsu, YM ;
Hung, KF ;
Lin, CJ ;
Hsieh, LL ;
Cheng, AJ .
CLINICAL BIOCHEMISTRY, 2002, 35 (08) :591-596
[7]  
CHEN CH, 1987, J FORMOSAN DENT ASS, V10, P268
[8]   Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area [J].
Chen, IH ;
Chang, JT ;
Liao, CT ;
Wang, HM ;
Hsieh, LL ;
Cheng, AJ .
BRITISH JOURNAL OF CANCER, 2003, 89 (04) :681-686
[9]  
Clayman GL, 1996, CANCER MED-US, V4th, P1645
[10]  
Daftary D.K., 1991, ORAL CANC CAMBRIDGE, VVolume 2, P29